Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.41M Sell
271,094
-32,567
-11% -$581K 0.01% 523
2026
Q1
$5.78M Buy
303,661
+132,225
+77% +$2.56M 0.01% 446
2025
Q4
$2.81M Buy
171,436
+46,651
+37% +$821K 0.01% 558
2025
Q3
$2.35M Hold
124,785
0.01% 566
2025
Q2
$2.52M Buy
124,785
+17,599
+16% +$304K 0.01% 548
2025
Q1
$1.47M Hold
107,186
﹤0.01% 634
2024
Q4
$1.27M Buy
107,186
+16,624
+18% +$262K ﹤0.01% 742
2024
Q3
$1.63M Buy
+90,562
New +$1.65M ﹤0.01% 638

Other funds holding XP

KBC Group's XP Position: Q2 2026 in Review

KBC Group reduced its XP (XP) stake by 11% in Q2 2026, selling an estimated $581K and leaving 271,094 shares worth $4.41M. The position accounts for 0.01% of the portfolio, ranked #523.

KBC Group first reported a position in XP in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.78M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • KBC Group held 271,094 shares of XP worth $4.41M as of Q2 2026.
  • KBC Group sold 32,567 XP shares in Q2 2026, an estimated $581K.
  • XP made up 0.01% of KBC Group's portfolio in Q2 2026, its #523 holding.
  • KBC Group first reported a position in XP in Q3 2024 and has held it in 8 quarters since.
  • KBC Group's XP position peaked at $5.78M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.